Real-time enrollment status for this ulcerative colitis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:13 PM UTC
| NCT Number | NCT06636656 |
| Recruiting Status | Recruiting |
| Condition | Ulcerative Colitis |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | June 2, 2026 (Jun 2, 2026) |
As of July 18, 2026: Clinical trial NCT06636656 is currently recruiting participants. This phase2 study for ulcerative colitis is actively seeking new participants at 14 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06636656 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06636656 was last updated Jun 2, 2026 (June 2, 2026). HelloStudys verifies this status automatically.